BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11801593)

  • 1. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
    Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
    J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.
    Brunet NM; Chase PB; Mihajlović G; Schoffstall B
    Arch Biochem Biophys; 2014 Jun; 552-553():11-20. PubMed ID: 24418317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.
    Wen Y; Pinto JR; Gomes AV; Xu Y; Wang Y; Wang Y; Potter JD; Kerrick WG
    J Biol Chem; 2008 Jul; 283(29):20484-94. PubMed ID: 18430738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils.
    Kruger M; Zittrich S; Redwood C; Blaudeck N; James J; Robbins J; Pfitzer G; Stehle R
    J Physiol; 2005 Apr; 564(Pt 2):347-57. PubMed ID: 15718266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect.
    Hornos F; Feng HZ; Rizzuti B; Palomino-Schätzlein M; Wieczorek D; Neira JL; Jin JP
    J Biol Chem; 2021; 296():100228. PubMed ID: 33814345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phosphorylation and mutation R145G on human cardiac troponin I function.
    Deng Y; Schmidtmann A; Redlich A; Westerdorf B; Jaquet K; Thieleczek R
    Biochemistry; 2001 Dec; 40(48):14593-602. PubMed ID: 11724573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
    Lindhout DA; Li MX; Schieve D; Sykes BD
    Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction.
    Harada K; Potter JD
    J Biol Chem; 2004 Apr; 279(15):14488-95. PubMed ID: 14722098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.
    Deng Y; Schmidtmann A; Kruse S; Filatov V; Heilmeyer LM; Jaquet K; Thieleczek R
    J Mol Cell Cardiol; 2003 Nov; 35(11):1365-74. PubMed ID: 14596793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
    J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development.
    Gomes AV; Liang J; Potter JD
    J Biol Chem; 2005 Sep; 280(35):30909-15. PubMed ID: 15961398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
    Burton D; Abdulrazzak H; Knott A; Elliott K; Redwood C; Watkins H; Marston S; Ashley C
    Biochem J; 2002 Mar; 362(Pt 2):443-51. PubMed ID: 11853553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
    Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
    J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
    Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
    Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ala scanning of the inhibitory region of cardiac troponin I.
    Kobayashi T; Patrick SE; Kobayashi M
    J Biol Chem; 2009 Jul; 284(30):20052-60. PubMed ID: 19483081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.
    Szczesna D; Zhang R; Zhao J; Jones M; Guzman G; Potter JD
    J Biol Chem; 2000 Jan; 275(1):624-30. PubMed ID: 10617660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.
    James J; Zhang Y; Osinska H; Sanbe A; Klevitsky R; Hewett TE; Robbins J
    Circ Res; 2000 Oct; 87(9):805-11. PubMed ID: 11055985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the NH(2)- and COOH-terminal domains of the inhibitory region of troponin I in the regulation of skeletal muscle contraction.
    Szczesna D; Zhang R; Zhao J; Jones M; Potter JD
    J Biol Chem; 1999 Oct; 274(41):29536-42. PubMed ID: 10506219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.